Indian firms that make active pharmaceutical ingredients, or APIs, are gearing up to supply the basic ingredient that goes in making copies of Novo Nordisk A/S’s weight-loss drugs that are losing patent protection next year in several large markets.
www.bloomberg.com
#India #Bulk #Drug #Makers #Start #Preparing #Ozempic #Patent #Expiry
India Bulk Drug Makers Start Preparing for Ozempic Patent Expiry
